ABM Q2 Call Reinforces Back-Half Margin Recovery Thesis

What happened

ABM Industries' Q2 earnings call reaffirmed fiscal 2026 EPS guidance, betting on a stronger second half driven by better ATS mix, M&D momentum, and cash flow generation. This comes after a Q1 where Technical Solutions margins compressed to 3.7%, and the stock dropped to ~$38, pricing in sustained margin pressure. Management explicitly tied the recovery to project timing normalization and restructuring savings, consistent with the prior thesis. However, skepticism remains as the Q2 results themselves haven't been disclosed yet, and the call's optimistic tone may be partly promotional. The market now awaits Q3 proof to validate the back-half weighting.

Implication

If the back-half recovery materializes as guided, the stock could re-rate to mid-$40s as leverage drops and EPS normalizes. But failure to deliver Technical Solutions margin improvement by Q3 would break the thesis, risking a re-test of $32. Monitor Q2 results for early signs of TS margin sequential improvement.

Thesis delta

The Q2 call provides no new information beyond reaffirmation, so the thesis remains unchanged. The key test—Technical Solutions margin recovery in 2H—is still unproven. No delta; maintain wait-and-see posture.